Journal: Biomedicines
Article Title: Trained Immunity in Bladder ILC3s Enhances Mucosal Defense Against Recurrent Urinary Tract Infections
doi: 10.3390/biomedicines14010078
Figure Lengend Snippet: ILC3s contribute to protection against UTI. ( a ) Schematic of the adoptive transfer and infection model. ( b – e ) Validation of ILC3 transfer: ILC3 counts ( b , c ) and representative flow cytometry plots ( d , e ) in bladder and kidney 24 h after UPEC challenge of mice received ILC3s or PBS transfer. ( f ) Schematic of experimental design. ( g ) Flow cytometry analysis of donor (CD45.1 + ) versus host (CD45.2 + ) ILC3s in recipient bladders. The orange polygon denotes CD45.1 + ILC3s, the black polygon denotes CD45.2 + white blood cells (WBCs), the black circle denotes CD45.2 + ILCs, and the blue polygon denotes CD45.2 + ILC3s. ( h , i ) Disease severity assessed by bladder/body weight ratio ( h ) and body weight change ( i ). ( j , k ) Bacterial load of bladders ( j ) and kidneys ( k ). ( l , m ) Representative immunofluorescence images ( l ) and mean fluorescence intensity (MFI) quantification ( m ) of UPEC (green) in bladder mucosa. Scale bars = 50 µm. ( n – p ) Bladder histopathology was assessed on H&E-stained sections ( n ), scale bars = 50 µm, with quantification of submucosal edema ( o ) and pathological scores ( p ). Data are shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, ns p > 0.05.
Article Snippet: Uropathogenic Escherichia coli ( E. coli ) strain CFT073 (ATCC 700928, isolated from an acute pyelonephritis patient’s clinical specimen) was used.
Techniques: Adoptive Transfer Assay, Infection, Biomarker Discovery, Flow Cytometry, Immunofluorescence, Fluorescence, Histopathology, Staining